2.4.0.6 Html 45 140 1 false 22 0 false 5 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.celltherapeutics.com/taxonomy/role/DocumentDocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.celltherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets (Unaudited) false false R3.htm 104 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.celltherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) false false R4.htm 105 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.celltherapeutics.com/taxonomy/role/StatementOfIncomeAlternative Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 106 - Statement - Condensed Consolidated Statements Of Comprehensive Loss (Unaudited) Sheet http://www.celltherapeutics.com/taxonomy/role/StatementOfOtherComprehensiveIncome Condensed Consolidated Statements Of Comprehensive Loss (Unaudited) false false R6.htm 107 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.celltherapeutics.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 108 - Disclosure - Description of Business and Summary of Significant Accounting Policies Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndAccountingPoliciesTextBlock Description of Business and Summary of Significant Accounting Policies false false R8.htm 109 - Disclosure - Inventory Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventory false false R9.htm 110 - Disclosure - Long-term Debt Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock Long-term Debt false false R10.htm 111 - Disclosure - Legal Proceedings Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsLegalMattersAndContingenciesTextBlock Legal Proceedings false false R11.htm 112 - Disclosure - Product Sales Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsSalesInformationTextBlock Product Sales false false R12.htm 113 - Disclosure - Share-based Compensation Expense Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Share-based Compensation Expense false false R13.htm 114 - Disclosure - Other Comprehensive Loss Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlock Other Comprehensive Loss false false R14.htm 115 - Disclosure - Leases Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsLeasesOfLesseeDisclosureTextBlock Leases false false R15.htm 116 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndAccountingPoliciesTextBlockPolicies Description of Business and Summary of Significant Accounting Policies (Policies) false false R16.htm 117 - Disclosure - Inventory (Tables) Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventory (Tables) false false R17.htm 118 - Disclosure - Product Sales (Tables) Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsSalesInformationTextBlockTables Product Sales (Tables) false false R18.htm 119 - Disclosure - Share-based Compensation Expense (Tables) Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Share-based Compensation Expense (Tables) false false R19.htm 120 - Disclosure - Other Comprehensive Loss (Tables) Sheet http://www.celltherapeutics.com/taxonomy/role/NotesToFinancialStatementsComprehensiveIncomeNoteTextBlockTables Other Comprehensive Loss (Tables) false false R20.htm 121 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformation Description of Business and Summary of Significant Accounting Policies - Additional Information (Detail) false false R21.htm 122 - Disclosure - Components of PIXUVRI Inventories (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureComponentsOfPIXUVRIInventories Components of PIXUVRI Inventories (Detail) false false R22.htm 123 - Disclosure - Long-term Debt - Additional Information (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureLongtermDebtAdditionalInformation Long-term Debt - Additional Information (Detail) false false R23.htm 124 - Disclosure - Legal Proceedings - Additional Information (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureLegalProceedingsAdditionalInformation Legal Proceedings - Additional Information (Detail) false false R24.htm 125 - Disclosure - Revenue From Product Sales of PIXUVRI (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureRevenueFromProductSalesOfPIXUVRI Revenue From Product Sales of PIXUVRI (Detail) false false R25.htm 126 - Disclosure - Summary of Share-Based Compensation Expense (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureSummaryOfShareBasedCompensationExpense Summary of Share-Based Compensation Expense (Detail) false false R26.htm 127 - Disclosure - Share-Based Compensation Expense by Types of Awards (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureShareBasedCompensationExpenseByTypesOfAwards Share-Based Compensation Expense by Types of Awards (Detail) false false R27.htm 128 - Disclosure - Total Accumulated Other Comprehensive Loss (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureTotalAccumulatedOtherComprehensiveLoss Total Accumulated Other Comprehensive Loss (Detail) false false R28.htm 129 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.celltherapeutics.com/taxonomy/role/DisclosureLeasesAdditionalInformation Leases - Additional Information (Detail) false false All Reports Book All Reports 'Monetary' elements on report '123 - Disclosure - Long-term Debt - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Mar. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 104 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 105 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 106 - Statement - Condensed Consolidated Statements Of Comprehensive Loss (Unaudited) Process Flow-Through: 107 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) ctic-20130331.xml ctic-20130331.xsd ctic-20130331_cal.xml ctic-20130331_def.xml ctic-20130331_lab.xml ctic-20130331_pre.xml true true